October 24, 2018

Oran B, Ciurea S, Marin D, et al. Safety Analysis of Intra-Patient Dose-Study Of […]

Learn more
October 24, 2018

Zimmerman EI, Turner DC, Buaboonnam J, et al. Crenolanib is Active Against Models of […]

Learn more
October 24, 2018

Blay J-Y, Heinrich MC, Hohenberger P, et al. A randomized, double-blind, placebo-controlled, phase III […]

Learn more
October 24, 2018

Arog Pharmaceuticals Presents Crenolanib Clinical Data at the 2017 American Society of Clinical Oncology […]

Learn more